Loading company details...
Beta
Latest Form 4 (Sep 14, 2026): Michelle LeRoux Williams (CHIEF SCIENTIFIC OFFICER): Exercise/Conversion of 12,500 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Michelle LeRoux Williams, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 12,500 | n/a |
| Sep 14, 2026 | Matthew Ferguson, CHIEF FINANCIAL OFFICER | Exercise/Conversion | 12,500 | n/a |
| Sep 14, 2026 | C. Randal Mills, PRESIDENT AND CEO | Exercise/Conversion | 27,083 | n/a |
| Jun 22, 2026 | C. Randal Mills, PRESIDENT AND CEO | Exercise/Conversion | 22,473 | n/a |
| Jun 15, 2026 | Kevin Rakin | Grant/Award | 159,590 | n/a |
| Jun 15, 2026 | David Colpman | Grant/Award | 106,393 | n/a |
| Jun 15, 2026 | Guido J. Neels | Grant/Award | 106,393 | n/a |
| Jun 15, 2026 | Brigid Makes | Grant/Award | 106,393 | n/a |
| Jun 12, 2026 | Michelle LeRoux Williams, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 12,500 | n/a |
| Jun 12, 2026 | Matthew Ferguson, CHIEF FINANCIAL OFFICER | Exercise/Conversion | 12,500 | n/a |